Farmacia Galénica y Tecnología Alimentaria
Département
Eli Lilly and Company
Indianapolis, EE. UU.Publications en collaboration avec des chercheurs de Eli Lilly and Company (4)
2019
2018
-
Predicting tumour growth and its impact on survival in gemcitabine-treated patients with advanced pancreatic cancer
European Journal of Pharmaceutical Sciences, Vol. 115, pp. 296-303
-
Systematic modeling and design evaluation of unperturbed tumor dynamics in xenografts
Journal of Pharmacology and Experimental Therapeutics, Vol. 366, Núm. 1, pp. 96-104
2017
-
Characterizing gemcitabine effects administered as single agent or combined with carboplatin in mice pancreatic and ovarian cancer xenografts: A semimechanistic pharmacokinetic/pharmacodynamics tumor growth-response model
Journal of Pharmacology and Experimental Therapeutics, Vol. 360, Núm. 3, pp. 445-456